Stockscreener 앱 받기
6.74
5.64%
0.36
전일 마감가:
$6.38
열려 있는:
$6.39
하루 거래량:
117.89K
Relative Volume:
1.24
시가총액:
$172.64M
수익:
-
순이익/손실:
$-22.38M
주가수익비율:
-4.7801
EPS:
-1.41
순현금흐름:
$-15.54M
1주 성능:
+11.22%
1개월 성능:
+14.63%
6개월 성능:
-23.93%
1년 성능:
+39.83%
1일 변동 폭
$6.39
$6.79
1주일 범위
$5.77
$6.79
52주 변동 폭
$4.44
$11.52
Nuvectis Pharma Inc Stock (NVCT) Company Profile
명칭
Nuvectis Pharma Inc
전화
360-837-7232
주소
1 BRIDGE PLAZA, SUITE 275, FORT LEE
NVCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
6.74 | 163.42M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Maxim Group | Buy |
| 2025-03-17 | 개시 | Laidlaw | Buy |
| 2022-07-13 | 개시 | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc 주식(NVCT)의 최신 뉴스
Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; individual investors who hold 44% profited and so did insiders - simplywall.st
Technical Reactions to NVCT Trends in Macro Strategies - news.stocktradersdaily.com
Nuvectis Pharma (NASDAQ:NVCT) Trading 9.8% Higher – Here’s What Happened - Defense World
Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright - Investing.com
Will Nuvectis Pharma Inc. stock attract more institutional investors2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Nuvectis Pharma Inc a good long term investmentStock Price Forecasts & High Return Capital Gains - earlytimes.in
Will Nuvectis Pharma Inc. stock split attract more investors2025 Price Momentum & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-11-30 11:27:46 - BỘ NỘI VỤ
Nuvectis Pharma to Host a Virtual Key Opinion Leader - GlobeNewswire
Trading the Move, Not the Narrative: (NVCT) Edition - news.stocktradersdaily.com
How Nuvectis Pharma Inc. stock reacts to Fed rate cutsWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Nuvectis Pharma Inc. (NVCT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Nuvectis Pharma Inc. stock trendline breakdownPortfolio Risk Summary & Stock Market Timing Techniques - newser.com
How currency fluctuations impact Nuvectis Pharma Inc. stockEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
What data driven models say about Nuvectis Pharma Inc.’s futureWeekly Gains Report & Reliable Volume Spike Trade Alerts - newser.com
Using RSI to spot recovery in Nuvectis Pharma Inc.Market Risk Report & Pattern Based Trade Signal System - newser.com
Predicting Nuvectis Pharma Inc. trend using moving averages2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Top Analysts Predictions for Indobell Insulation Limited Stock Over 12 MonthsInsider Trading Activity & Free Unstoppable Trading Performance - earlytimes.in
What makes Nuvectis Pharma Inc. stock attractive to growth fundsMarket Volume Summary & Smart Investment Allocation Insights - newser.com
(NVCT) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Why Nuvectis Pharma Inc. stock remains undervaluedWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
How Nuvectis Pharma Inc. stock performs in rate cut cycles2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Director of Nuvectis Pharma Juan Sanchez Buys 20% More Shares - Yahoo Finance
Matthew Kaplan Acquires 11,000 Shares of Nuvectis Pharma (NASDAQ:NVCT) Stock - MarketBeat
Roth Capital Expects Lower Earnings for Nuvectis Pharma - Defense World
HC Wainwright Cuts Earnings Estimates for Nuvectis Pharma - Defense World
Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Nuvectis Pharma director Sanchez buys $75k in NVCT stock By Investing.com - Investing.com Canada
Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240 By Investing.com - Investing.com South Africa
Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvect - GuruFocus
Nuvectis Pharma director Sanchez buys $75k in NVCT stock - Investing.com
Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240 - Investing.com
Nuvectis Pharma chairman Bentsur buys $28,600 in shares By Investing.com - Investing.com Canada
Nuvectis Pharma chairman Bentsur buys $28,600 in shares - Investing.com
Nuvectis Pharma Inc (NVCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):